| Prev Close | 89.13 |
| Open | 89.31 |
| Day Low/High | 88.21 / 90.64 |
| 52 Wk Low/High | 48.26 / 99.25 |
| Volume | 183.57K |
| Avg Volume | 575.20K |
Repligen Corp. (RGEN)
88.61
0.52
0.58
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 52.06M |
| Market Cap | 4.70B |
| EPS | 0.40 |
| P/E Ratio | 181.54 |
| Div & Yield | N.A. (N.A) |
Latest News
Drug Stocks Find Trump Animus a Bitter Pill
The president-elect's words rattled the sector, though Amgen appears to be shrugging off his remarks.
5 Health Care Stocks Set to Bounce
These stocks are down some 20% over the last 30 months and look ripe for a rise.
Repligen Has More Upside Ahead
Add to longs on a short-term correction.
Where the Money Was Made the Last 5 Years
Only one fund category (of 20) has beaten the S&P 500 over half a decade.
The Trader Daily
Don't batten down the hatches yet.
Some Weekend Folding Money
I'm content to head into the weekend with my short-term book mostly on the cash side.
Biotech Breakouts
Favorable charts for Celldex, Repligen and Arrowhead Research.
